XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Supplemental Consolidated Financial Information (Tables)
6 Months Ended
Jun. 30, 2022
Balance Sheet Components [Abstract]  
Schedule of cash and cash equivalents
Cash, cash equivalents and restricted cash
June 30,
2022
December 31,
2021
(In millions)
Cash and cash equivalents$1,742 $1,379 
Customer accounts— 
Restricted cash included in short-term investments26 22 
Restricted cash included in long-term investments— 
Cash, cash equivalents and restricted cash$1,772 $1,406 
Restrictions on cash and cash equivalents
Cash, cash equivalents and restricted cash
June 30,
2022
December 31,
2021
(In millions)
Cash and cash equivalents$1,742 $1,379 
Customer accounts— 
Restricted cash included in short-term investments26 22 
Restricted cash included in long-term investments— 
Cash, cash equivalents and restricted cash$1,772 $1,406 
Customer accounts and funds receivable
Customer accounts and funds receivable
June 30,
2022
December 31,
2021
(In millions)
Cash and cash equivalents$— $
Funds receivable605 676 
Customer accounts and funds receivable$605 $681 
Schedule of other current assets
Other current assets
June 30,
2022
December 31,
2021
(In millions)
Payment processor advances$405 $453 
Short-term derivative assets204 86 
Prepaid expenses117 114 
Income and other tax receivable140 108 
Accounts receivable, net82 98 
Other289 248 
Other current assets$1,237 $1,107 
Schedule of accrued expenses and other current liabilities
Accrued expenses and other current liabilities
June 30,
2022
December 31,
2021
(In millions)
Compensation and related benefits$363 $517 
Sales and use tax and VAT accruals316 396 
Advertising accruals236 172 
Operating lease liabilities144 150 
Transaction loss reserve117 116 
Uninvoiced general and administrative expenses104 95 
Accrued interest expense59 74 
Deferred revenue33 79 
Other363 328 
Accrued expenses and other current liabilities$1,735 $1,927 
Schedule of gain (loss) on equity method investments and warrants
Gain (loss) on equity investments and warrant, net
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
(In millions)
Change in fair value of equity investment in Adevinta$(829)$(422)$(2,472)$(422)
Change in fair value of equity investment in Gmarket
(77)— (259)— 
Unrealized change in fair value of equity investment in KakaoBank(105)— (196)— 
Unrealized change in fair value of equity investment in Adyen(38)— (118)— 
Realized change in fair value of shares sold in Adyen(1)— (167)— 
Realized change in fair value of shares sold in KakaoBank(67)— (75)— 
Change in fair value of warrant(104)108 (219)72 
Gain (loss) on other investments— 41 (6)41 
Total gain (loss) on equity investments and warrant, net$(1,221)$(273)$(3,512)$(309)